Growth Metrics

Burning Rock Biotech (BNR) Other Non-Current Liabilities (2020 - 2025)

Burning Rock Biotech has reported Other Non-Current Liabilities over the past 6 years, most recently at $1.7 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 16.33% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $1.7 million, up 16.33%, while the annual FY2025 figure was $1.7 million, 19.89% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $1.7 million at Burning Rock Biotech, up from $1.6 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $6.5 million in Q3 2022 and troughed at $35000.0 in Q1 2021.
  • A 5-year average of $1.4 million and a median of $702000.0 in 2024 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 18408.57% in 2022 and later tumbled 92.67% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $1.8 million in 2021, then plummeted by 68.52% to $579851.2 in 2022, then grew by 8.67% to $630132.1 in 2023, then skyrocketed by 130.32% to $1.5 million in 2024, then rose by 16.33% to $1.7 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for BNR at $1.7 million in Q4 2025, $1.6 million in Q3 2025, and $1.5 million in Q2 2025.